Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73:17–48
Blackford AL, Canto MI, Klein AP et al (2020) Recent trends in the incidence and survival of stage 1A pancreatic Cancer: a Surveillance, Epidemiology, and end results analysis. J Natl Cancer Inst 112:1162–1169
Article PubMed PubMed Central Google Scholar
Overbeek KA, Levink IJM, Koopmann BDM et al (2022) Long-term yield of pancreatic cancer surveillance in high-risk individuals. Gut 71:1152–1160
Article CAS PubMed Google Scholar
Klatte DCF, Boekestijn B, Onnekink AM et al (2023) Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis. Gastroenterology. ; 164: 1223–1231 e1224
Shah I, Silva-Santisteban A, Germansky KA et al (2023) Pancreatic Cancer screening for At-Risk individuals (pancreas scan study): yield, Harms, and outcomes from a prospective Multicenter Study. Am J Gastroenterol 118:1664–1670
Dbouk M, Katona BW, Brand RE et al (2022) The Multicenter Cancer of pancreas Screening Study: Impact on Stage and Survival. J Clin Oncol 40:3257–3266
Article CAS PubMed PubMed Central Google Scholar
Bartsch DK, Matthai E, Mintziras I et al (2021) The German National Case Collection for familial pancreatic carcinoma (FaPaCa)-Knowledge gained in 20 years. Dtsch Arztebl Int 118:163–168
Gangi A, Malafa M, Klapman J (2018) Endoscopic ultrasound-based pancreatic Cancer screening of high-risk individuals: a prospective observational trial. Pancreas 47:586–591
Chang MC, Wu CH, Yang SH et al (2017) Pancreatic cancer screening in different risk individuals with family history of pancreatic cancer-a prospective cohort study in Taiwan. Am J Cancer Res 7:357–369
CAS PubMed PubMed Central Google Scholar
Del Chiaro M, Verbeke CS, Kartalis N et al (2015) Short-term results of a magnetic resonance imaging-based Swedish screening program for individuals at risk for pancreatic Cancer. JAMA Surg 150:512–518
Mocci E, Guillen-Ponce C, Earl J et al (2015) PanGen-Fam: Spanish registry of hereditary pancreatic cancer. Eur J Cancer 51:1911–1917
Article CAS PubMed Google Scholar
Canto MI, Goggins M, Yeo CJ et al (2004) Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol 2:606–621
Gonda TA, Everett JN, Wallace M et al (2021) Recommendations for a more Organized and Effective Approach to the early detection of Pancreatic Cancer from the PRECEDE (pancreatic Cancer Early Detection) Consortium. Gastroenterology 161:1751–1757
Gonda TA, Farrell J, Wallace M et al (2022) Standardization of EUS imaging and reporting in high-risk individuals of pancreatic adenocarcinoma: consensus statement of the pancreatic Cancer Early Detection Consortium. Gastrointest Endosc 95:723–732e727
Huang C, Simeone DM, Luk L et al (2022) Standardization of MRI screening and reporting in individuals with elevated risk of pancreatic ductal adenocarcinoma: Consensus Statement of the PRECEDE Consortium. AJR Am J Roentgenol 219:903–914
Del Chiaro M, Zerbi A, Capurso G et al (2010) Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: a position paper from the Italian Registry. Dig Liver Dis 42:597–605
Wang W, Chen S, Brune KA et al (2007) PancPRO: risk assessment for individuals with a family history of pancreatic cancer. J Clin Oncol 25:1417–1422
Maisonneuve P, Marshall BC, Lowenfels AB (2007) Risk of pancreatic cancer in patients with cystic fibrosis. Gut 56:1327–1328
Article CAS PubMed PubMed Central Google Scholar
Raimondi S, Maisonneuve P, Lohr JM, Lowenfels AB (2007) Early onset pancreatic cancer: evidence of a major role for smoking and genetic factors. Cancer Epidemiol Biomarkers Prev 16:1894–1897
Paiella S, Salvia R, De Pastena M et al (2018) Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: a systematic review and proportion meta-analysis of screening results. Pancreatology 18:420–428
Paiella S, Secchettin E, Lionetto G et al (2023) Surveillance of individuals at high risk of developing pancreatic Cancer: a prevalence meta-analysis to Estimate the rate of low-yield surgery. Ann Surg
Hruban RH, Maitra A, Goggins M (2008) Update on pancreatic intraepithelial neoplasia. Int J Clin Exp Pathol 1:306–316
CAS PubMed PubMed Central Google Scholar
Canto MI, Harinck F, Hruban RH et al (2013) International Cancer of the pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut 62:339–347
Howes N, Lerch MM, Greenhalf W et al (2004) Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol 2:252–261
Article CAS PubMed Google Scholar
Bartsch DK, Sina-Frey M, Ziegler A et al (2001) Update Familial Pancreat cancer Ger Pancreatology 1:510–516
Balzano G, Capretti G, Callea G et al (2016) Overuse of surgery in patients with pancreatic cancer. A nationwide analysis in Italy. HPB (Oxford) 18:470–478
Paiella S, Capurso G, Cavestro GM et al (2019) Results of First-Round of Surveillance in individuals at high-risk of pancreatic Cancer from the AISP (Italian Association for the study of the Pancreas) Registry. Am J Gastroenterol 114:665–670
Capurso G, Paiella S, Carrara S et al (2020) Italian registry of families at risk of pancreatic cancer: AISP Familial Pancreatic Cancer Study Group. Dig Liver Dis 52:1126–1130
Hu C, Hart SN, Polley EC et al (2018) Association between inherited germline mutations in Cancer Predisposition genes and risk of pancreatic Cancer. JAMA 319:2401–2409
Article CAS PubMed PubMed Central Google Scholar
Rainone M, Singh I, Salo-Mullen EE et al (2020) An emerging paradigm for Germline Testing in Pancreatic Ductal Adenocarcinoma and Immediate implications for clinical practice: a review. JAMA Oncol 6:764–771
Paiella S, Capurso G, Carrara S et al (2023) Outcomes of a 3-year prospective surveillance in individuals at high-risk for pancreatic cancer. Am J Gastroenterol
Goggins M, Overbeek KA, Brand R et al (2020) Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the pancreas Screening (CAPS) Consortium. Gut 69:7–17
Article CAS PubMed Google Scholar
Pujol P, Barberis M, Beer P et al (2021) Clinical practice guidelines for BRCA1 and BRCA2 genetic testing. Eur J Cancer 146:30–47
Article CAS PubMed Google Scholar
Russo A, Incorvaia L, Capoluongo E et al (2022) Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific societies. ESMO Open 7:100459
Article CAS PubMed PubMed Central Google Scholar
Canto MI, Almario JA, Schulick RD et al (2018) Risk of neoplastic progression in individuals at high risk for pancreatic Cancer Undergoing Long-Term Surveillance. Gastroenterology 155:740–751 e742
Fondazione N Valsecchi. In
Associazione Oltre la Ricerca ODV. In
Furniss CS, Yurgelun MB, Ukaegbu C et al (2021) Novel Models of Genetic Education and Testing for Pancreatic Cancer interception: preliminary results from the GENERATE Study. Cancer Prev Res (Phila) 14:1021–1032
Comments (0)